Atlas Trials

Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma

Clinical trial NCT06331260 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06331260
Sponsor
Zhejiang University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Liver TransplantationHepatocellular CarcinomaAlpha-FetoproteinProtein Induced by Vitamin K Absence or Antagonist-II
Start date
2024-04-01
Primary completion
2028-04-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.